Run Lin
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Nanoplatforms for cancer theranostics 5
- Graphene and Nanomaterials Applications 4
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Weiling He (8 shared papers)Jin‐Zhi Du (4 shared papers)Jing Huang (6 shared papers)Hui Mao (6 shared papers)Jun Wang (2 shared papers)Hongjun Li (1 shared paper)Lily Yang (4 shared papers)Zunfu Ke (3 shared papers)
- Journals
- Journal of Materials Chemistry B (3 papers)Frontiers in Oncology (2 papers)Biomaterials Science (2 papers)Molecular Cancer (1 paper)Frontiers in Pediatrics (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Run Lin
40 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Biomaterials 425
- Immunology 316
- Oncology 343
- Pharmaceutical Science 82
- Cancer Research 152
Countries citing papers authored by Run Lin
This map shows the geographic impact of Run Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Lin more than expected).
Fields of papers citing papers by Run Lin
This network shows the impact of papers produced by Run Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Lin. The network helps show where Run Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Run Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 267 | |
| 2 | 2018 | 240 | |
| 3 | 2020 | 179 | |
| 4 | 2013 | 148 | |
| 5 | 2020 | 85 | |
| 6 | 2021 | 64 | |
| 7 | 2017 | 58 | |
| 8 | 2015 | 56 | |
| 9 | 2019 | 54 | |
| 10 | 2016 | 42 | |
| 11 | 2018 | 36 | |
| 12 | 2022 | 35 | |
| 13 | 2013 | 27 | |
| 14 | 2023 | 27 | |
| 15 | 2021 | 27 | |
| 16 | 2024 | 23 | |
| 17 | 2021 | 22 | |
| 18 | 2020 | 21 | |
| 19 | 2024 | 20 | |
| 20 | 2020 | 13 |
About Run Lin
Run Lin is a scholar working on Biomedical Engineering, Biomaterials, Hepatology, Molecular Biology and Oncology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (5 papers), Graphene and Nanomaterials Applications (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (2 papers), Cancer Mechanisms and Therapy (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Biomaterials (425 citations), Immunology (316 citations), Oncology (343 citations), Pharmaceutical Science (82 citations) and Cancer Research (152 citations). Run Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Weiling He, Jin‐Zhi Du, Jing Huang, Hui Mao, Jun Wang, Hongjun Li, Lily Yang, Zunfu Ke, Hui Zhang and Yonghui Huang. Their work appears in journals such as Journal of Materials Chemistry B, Frontiers in Oncology, Biomaterials Science, Molecular Cancer and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.